308 related articles for article (PubMed ID: 35874757)
1. Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy.
Xu C; Ju D; Zhang X
Front Immunol; 2022; 13():923598. PubMed ID: 35874757
[TBL] [Abstract][Full Text] [Related]
2. CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin.
Jang Y; Cho YS; Kim A; Zhou X; Kim Y; Wan Z; Moon JJ; Park H
ACS Appl Mater Interfaces; 2024 Apr; 16(14):17129-17144. PubMed ID: 38533538
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy.
Xiao Y; Wu M; Xue C; Wang Y
Curr Drug Deliv; 2024; 21(3):403-420. PubMed ID: 37143265
[TBL] [Abstract][Full Text] [Related]
4. Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy.
An X; Zeng Y; Liu C; Liu G
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258033
[TBL] [Abstract][Full Text] [Related]
5. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
6. Extracellular-Vesicle-Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer-Immunity Cycle.
Yong T; Wei Z; Gan L; Yang X
Adv Mater; 2022 Dec; 34(52):e2201054. PubMed ID: 35726204
[TBL] [Abstract][Full Text] [Related]
7. Genetically Engineered-Cell-Membrane Nanovesicles for Cancer Immunotherapy.
Cheng Q; Kang Y; Yao B; Dong J; Zhu Y; He Y; Ji X
Adv Sci (Weinh); 2023 Sep; 10(26):e2302131. PubMed ID: 37409429
[TBL] [Abstract][Full Text] [Related]
8. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
9. Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy.
Long Q; Zheng P; Zheng X; Li W; Hua L; Yang Z; Huang W; Ma Y
Adv Drug Deliv Rev; 2022 Jul; 186():114321. PubMed ID: 35533789
[TBL] [Abstract][Full Text] [Related]
10. Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy.
Yang P; Peng Y; Feng Y; Xu Z; Feng P; Cao J; Chen Y; Chen X; Cao X; Yang Y; Jie J
Front Immunol; 2021; 12():771551. PubMed ID: 34956197
[TBL] [Abstract][Full Text] [Related]
11. Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
Zuo S; Song J; Zhang J; He Z; Sun B; Sun J
Theranostics; 2021; 11(15):7471-7487. PubMed ID: 34158861
[TBL] [Abstract][Full Text] [Related]
12. Engineered drug-loaded cells and cell derivatives as a delivery platform for cancer immunotherapy.
Wang L; Liu J
Biomater Sci; 2021 Feb; 9(4):1104-1116. PubMed ID: 33201163
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the therapeutic potential of extracellular vesicles for cancer treatment.
Zhang Y; Xiao Y; Sun G; Jin X; Guo L; Li T; Yin H
Semin Cancer Biol; 2021 Sep; 74():92-104. PubMed ID: 33962020
[TBL] [Abstract][Full Text] [Related]
14. Cell-Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy.
Fan X; Wang K; Lu Q; Lu Y; Sun J
Small; 2023 Jan; 19(4):e2205166. PubMed ID: 36437050
[TBL] [Abstract][Full Text] [Related]
15. Advances in herbal polysaccharides-based nano-drug delivery systems for cancer immunotherapy.
Han MM; Fan YK; Zhang Y; Dong ZQ
J Drug Target; 2024 Dec; 32(3):311-324. PubMed ID: 38269853
[TBL] [Abstract][Full Text] [Related]
16. Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response.
Kim OY; Park HT; Dinh NTH; Choi SJ; Lee J; Kim JH; Lee SW; Gho YS
Nat Commun; 2017 Sep; 8(1):626. PubMed ID: 28931823
[TBL] [Abstract][Full Text] [Related]
17. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
Tian X; Zhu M; Nie G
Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
[TBL] [Abstract][Full Text] [Related]
18. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor.
Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y
Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120
[TBL] [Abstract][Full Text] [Related]
19. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
[TBL] [Abstract][Full Text] [Related]
20. Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention.
Chen Q; Bai H; Wu W; Huang G; Li Y; Wu M; Tang G; Ping Y
Nano Lett; 2020 Jan; 20(1):11-21. PubMed ID: 31858807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
